普通外文研报
Equity Strategy "The Theme-ometer: What to buy if not AI" Fowler
研报英文原文证据摘录
Equity Strategy "The Theme-ometer: What to buy if not AI" Fowler
Global Research
17 June 2026ab
Equity Strategy Equity Strategy
AmericasThe Theme-ometer: What to buy if not AI
Gerry Fowler
Strategist
A market of themes gerry.fowler@ubs.com
+44-20-7567 5490
REVS is our quantamental stock selection framework. Our philosophy is that stock prices
are impacted by the macroeconomic regime (R), earnings (E), valuations (V), and Sean Simonds
Strategistsentiment (S). Across 11 models, we have a comprehensive tactical framework (2-6
sean.simonds@ubs.com
months). Each model backtests well and they work well together. We aggregate stock +1-212-713 2851
scores to assess equity themes as well as indices, sectors and industry groups globally.
Maxwell Grinacoff, CFA
Most Preferred Themes
maxwell.grinacoff@ubs.com
Healthcare emerges as a leading complement to AI: The most notable shift in +1-212-713 3892
the signals is in healthcare globally, with the GLP-1 Winners theme now ranking at
Nicolas Le Roux
the top after spending months mid-table. This reflects improving earnings Strategist
revisions alongside more attractive valuations. See our top picks in the US here. nicolas.le-roux@ubs.com
+33-14-953 2118
AI capex still strong, but increasingly selective: AI Winners and AI-exposed
Semis remain supported by positive earnings revisions and a favourable regime Andrew Garthwaite
backdrop. However, crowding and valuation headwinds continue to moderate the Strategist
aggregate signal, pointing to a more selective approach within the theme. andrew.garthwaite@ubs.com
+44-20-7567 4343
US growth momentum driving a ‘broadening’ trade: Stronger US data is Bhanu Baweja
feeding through into the signals, with US Reshoring and Short Cycle Industrials Strategist
rising into clearly positive territory.
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器